JEFFREY L EDWARDS
CIK 1190642 · EVP, Fin & Bus. Dev., CFO · last filed 2026-04-23
JEFFREY L EDWARDS is an EVP, Fin & Bus. Dev., CFO who has filed 58 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for BIO.B, was dated Apr 23, 2026. Across all open-market trades the lifetime net is −$59.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $666.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$666.8K
6
58
-$59.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIO.B | Director | 715 | $304.15 | $217.5K | $0 | 3 | 2026-04-23 |
| KYNTRA BIO, INC. (FGEN) Delisted | Director | 41,866 | $9.75 | $408.2K | -$135.6K | 11 | 2025-06-06 |
| LFCR | Director | 79,667 | $5.64 | $449.3K | $0 | 5 | 2024-07-10 |
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | — | $0.35 | — | $0 | 7 | 2024-06-21 |
| LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted | Director | 12,457 | $8.76 | $109.1K | $0 | 5 | 2022-06-07 |
| ALLERGAN INC (AGN) Delisted | EVP, Fin & Bus. Dev., CFO | 58,153 | — | — | -$59.07M | 27 | 2014-02-25 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-23 | BIO.B | Mixed | +407 | $0 | EDGAR |
| 2025-06-06 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-04-24 | BIO.B | Mixed | +308 | $0 | EDGAR |
| 2024-09-10 | BIO.B | Grant (A) | — | $0 | EDGAR |
| 2024-07-10 | LFCR | Grant (A) | +30,000 | $0 | EDGAR |
| 2024-06-21 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | KYNTRA BIO, INC. (FGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-02 | LFCR | Exer (M) | +9,554 | $0 | EDGAR |
| 2023-06-23 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | KYNTRA BIO, INC. (FGEN) Delisted | Mixed | +400 | -$135.6K | EDGAR |